ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.26
0.33%
US Tech 100
19,884.80
0.46%
S&P 500
5,631.22
0.28%
US Dollar vs CAD
1.36845
0.04%
Bitcoin
64,571.76
-0.43%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Newellis Inc (NUWE)

  7. Newellis Inc (NUWE) News

NUWE

Newellis (NUWE)

Newellis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NUWE
DateTimeSourceHeadlineSymbolCompany
02/23/20233:15PMGlobeNewswire Inc.Nuwellis to Present at the Oppenheimer 33rd Annual Healthcare ConferenceNASDAQ:NUWENewellis Inc
02/23/20237:00AMGlobeNewswire Inc.Clinical Data Supports the Role of Ultrafiltration in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI)NASDAQ:NUWENewellis Inc
02/13/20233:38PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NUWENewellis Inc
02/07/20237:00AMGlobeNewswire Inc.Nuwellis, Inc. To Announce Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023NASDAQ:NUWENewellis Inc
01/09/20237:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
01/09/20237:00AMGlobeNewswire Inc.Nuwellis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue ResultsNASDAQ:NUWENewellis Inc
01/05/20231:40PMGlobeNewswire Inc.Nuwellis Appoints Dr. John Jefferies as Chief Medical OfficerNASDAQ:NUWENewellis Inc
01/04/20234:24PMGlobeNewswire Inc.Nuwellis, Inc. Announces Passage of Warrant ProposalNASDAQ:NUWENewellis Inc
12/29/202212:34PMGlobeNewswire Inc.SeaStar Medical and Nuwellis Enter into a U.S. License and Distribution Agreement for SeaStar Medical’s Selective Cytopheretic Device (SCD) for Pediatric Acute Kidney Injury (AKI)NASDAQ:NUWENewellis Inc
12/29/20228:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
12/28/20224:02PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NUWENewellis Inc
12/27/20224:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
12/27/20223:44PMGlobeNewswire Inc.Nuwellis, Inc. Announces Compliance With Nasdaq Listing RequirementsNASDAQ:NUWENewellis Inc
12/13/20227:00AMGlobeNewswire Inc.Nuwellis Announces Data Supporting Lower Heart Failure Hospitalizations and Readmissions With AquadexNASDAQ:NUWENewellis Inc
12/09/20224:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
12/09/20227:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
12/08/20227:10AMGlobeNewswire Inc.Nuwellis, Inc. Announces Adjournment of Special Meeting of Stockholders Due to Lack of QuorumNASDAQ:NUWENewellis Inc
12/06/20225:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
11/30/20227:00AMGlobeNewswire Inc.Nuwellis, Inc. Receives 180-Day Extension to Meet Nasdaq Minimum Bid Price RequirementNASDAQ:NUWENewellis Inc
11/18/20224:00PMGlobeNewswire Inc.Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NUWENewellis Inc
11/10/20226:51AMTipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:NUWENewellis Inc
11/08/20227:00AMGlobeNewswire Inc.Nuwellis, Inc. Reports Third Quarter 2022 Financial ResultsNASDAQ:NUWENewellis Inc
11/08/20225:05AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NUWENewellis Inc
11/08/20225:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUWENewellis Inc
11/07/20224:29PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NUWENewellis Inc
11/07/20224:13PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NUWENewellis Inc
11/03/20226:00AMGlobeNewswire Inc.Nuwellis Announces Peer Reviewed Data Demonstrating 71% Survival with Kidney Replacement Therapy Using a Modified Aquadex in Low-Birth-Weight Preterm NeonatesNASDAQ:NUWENewellis Inc
10/28/20224:37PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:NUWENewellis Inc
10/28/20223:59PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NUWENewellis Inc
10/19/20223:15PMGlobeNewswire Inc.Nuwellis, Inc. To Announce Third Quarter 2022 Financial Results on November 8, 2022NASDAQ:NUWENewellis Inc
 Showing the most relevant articles for your search:NASDAQ:NUWE

Your Recent History

USOTC
AXXA
Exxe (PK)
USOTC
MGON
Megola (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
IQST
iQSTEL (QX)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
GRST
Ethema Health (PK)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
RNVA
Rennova Health (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved